Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders ...

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience ...

Amado, M.D., President, Head of Global Research and Development at Zai Lab. LRRC15 is a type I transmembrane protein and an appealing target for cancer therapy because it is overexpressed in ...

A two-year journey with Team Liquid comes to an end for Ludwig "zai" Wåhlberg in the TI12 aftermath. Post TI 2023 roster shuffle is kicking off and one of the first to make a change are Team Liquid, ...

Zai Lab Limited (ZLAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Zai Lab ...